Correlation Between CD133+ Stem Cells and Clinical Improvement in Patients with Autism Spectrum Disorders Treated with Intrathecal Bone Marrow-derived Mononuclear Cells.
Year: 2022
Type: article
Abstract: =0.01; r= -0.60) posttreatment positively correlated with the enrichment of a putative BM stem cell population expressing the cluster of differentiation 133+ (CD133+) surface marker.
Source: PubMed
Authors: Laura Villarreal-Martinez, Laura Elia MartÍnez-Garza, Iram Pablo Rodriguez-Sanchez, Neri Alvarez-Villalobos, Fernando Guzman-Gallardo, Sulia Pope-Salazar, Cynthia Salinas-Silva, Maria Guadalupe Cepeda-Cepeda, Alejandra Garza-Bedolla, Irving Armando Dominguez-Varela, Daniel Zacarias Villarreal-Martinez, Jose Humberto Treviño-Villarreal, David Gomez-Almaguer
Institution: Hospital Universitario Dr José Eleuterio Gonzalez
Language: English
Subfield: Cell Biology
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W4291674127